These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15933067)

  • 21. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prothrombin 20210A-associated thrombosis may need concurrency of another prothrombotic factor.
    Espinoza J; Llamas P; Fernández de Velasco J; Soto C; Román A; Tomás JF
    Thromb Res; 2001 May; 102(4):381-3. PubMed ID: 11421234
    [No Abstract]   [Full Text] [Related]  

  • 23. Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis.
    Kruthika-Vinod TP; Nagaraja D; Christopher R
    J Clin Neurosci; 2012 Jan; 19(1):190-1. PubMed ID: 22136731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations at the activated protein C cleavage sites Arg336 and Arg562 of factor VIII in Thai patients with venous thrombosis.
    Prayoonwiwat W; Arnutti P; Nathalang O; Suwanasophon C; Viputtigul K
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):880-3. PubMed ID: 12041568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Marburg I polymorphism of Factor VII-activating protease and cerebral infarction].
    Tan Q; Tang H; Liu R; Wang G; Yang X; Chen F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 34(12):1171-5. PubMed ID: 20045910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?
    Aras O; Hanson NQ; Tsai MY; Key NS
    Thromb Haemost; 2002 Jan; 87(1):173-4. PubMed ID: 11848451
    [No Abstract]   [Full Text] [Related]  

  • 29. 10q26 is associated with increased risk of age-related macular degeneration in the Utah population.
    Cameron DJ; Yang Z; Tong Z; Zhao Y; Praggastis A; Brinton E; Harmon J; Chen Y; Pearson E; Bernstein PS; Brinton G; Li X; Jorgensen A; Schneider S; Gibbs D; Chen H; Wang C; Howes K; Camp NJ; Zhang K
    Adv Exp Med Biol; 2008; 613():253-8. PubMed ID: 18188952
    [No Abstract]   [Full Text] [Related]  

  • 30. A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis.
    Corral J; González-Conejero R; Soria JM; González-Porras JR; Pérez-Ceballos E; Lecumberri R; Roldán V; Souto JC; Miñano A; Hernández-Espinosa D; Alberca I; Fontcuberta J; Vicente V
    Blood; 2006 Jul; 108(1):177-83. PubMed ID: 16527896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association of non-synonymous FUT2 and ALPL polymorphisms with venous thrombosis.
    Tregouet DA; Sabater-Lleal M; Bruzelius M; Emmerich J; Amouyel P; Dartigues JF; Kieler H; Morange PE
    J Thromb Haemost; 2012 Aug; 10(8):1693-5. PubMed ID: 22672431
    [No Abstract]   [Full Text] [Related]  

  • 32. The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.
    Wasmuth HE; Tag CG; Van de Leur E; Hellerbrand C; Mueller T; Berg T; Puhl G; Neuhaus P; Samuel D; Trautwein C; Kanse SM; Weiskirchen R
    Hepatology; 2009 Mar; 49(3):775-80. PubMed ID: 19105210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Homocysteine, 5,10-methylenetetrahydrofolate reductase and deep venous thrombosis. Survey of 120 patients in internal medicine].
    Quéré I; Chassé JF; Dupuy E; Bellet E; Molho-Sabatier P; Tobelem G; Janbon C
    Rev Med Interne; 1998 Jan; 19(1):29-33. PubMed ID: 9775112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
    Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
    Bezemer ID; Doggen CJ; Vos HL; Rosendaal FR
    Arch Intern Med; 2007 Mar; 167(5):497-501. PubMed ID: 17353498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY).
    Pieroni F; Lourenço DM; Morelli VM; Maffei FH; Zago MA; Franco RF
    Thromb Res; 2007; 120(2):221-9. PubMed ID: 17113632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylenetetrahydrofolate-dehydrogenase 1958 G-A (R653 Q) polymorphism in Turkish patients with venous thromboembolism.
    Akar N; Akar E
    Acta Haematol; 1999; 102(4):199-200. PubMed ID: 10725763
    [No Abstract]   [Full Text] [Related]  

  • 38. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.
    Philipp CS; Dilley A; Saidi P; Evatt B; Austin H; Zawadsky J; Harwood D; Ellingsen D; Barnhart E; Phillips DJ; Hooper WC
    Thromb Haemost; 1998 Dec; 80(6):869-73. PubMed ID: 9869151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
    Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
    Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two missense mutations identified in venous thrombosis patients impair the inhibitory function of the protein Z dependent protease inhibitor.
    Young LK; Birch NP; Browett PJ; Coughlin PB; Horvath AJ; Van de Water NS; Ockelford PA; Harper PL
    Thromb Haemost; 2012 May; 107(5):854-63. PubMed ID: 22399118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.